A defining attribute of AD is the aggregation of Aβ plaques, resulting from modifications in the regulatory pathways of Aβ, managed by APP and BACE1.305 Due to BACE1’s role in Aβ clearance, it is a noteworthy element in the progression of AD. Here, BACE1 is linked to Alzheimer disease.